Supporting individuals and organisations

Improving the phage selection protocol for the treatment of the cystic fibrosis patients with multidrug-resistant lung infections

Vascular & immune microenvironments in patients with CF-associated liver disease

Magnitude, mechanisms and clinical relevance of differences in the response to CFTR modulator in rectal organoids from patients with CF homozygous for the F508del mutation

A gene editing strategy for refractory CFTR mutations causing cystic fibrosis

In depth characterisation of the site and nature of airway obstruction and associated vascular remodeling in cystic fibrosis

Charcot-Leyden crystals and Galectin-10 as potential diagnostic and therapeutic target in cystic fibrosis-associated allergic bronchopulmonary aspergillosis (ABPA)